Inventor · disambiguated record
Tilmann Roos
Also filed as: ROOS TILMANN
19 granted patents·23 pending applications·238 citations·filing 2003–2025
94Inventor score
Files withCureVac SE17CUREVAC AG13CUREVAC MFG GMBH6CUREVAC REAL ESTATE GMBH2CureVac RNA Printer GmbH1
Top patents by PatentIndex Score
42 records- 0198US11433027B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2020·Granted Sep 6, 2022·15 cites·25 claims
- 0298US11179337B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2019·Granted Nov 23, 2021·35 cites·28 claims
- 0398US10729654B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2016·Granted Aug 4, 2020·36 cites·15 claims
- 0497US11534405B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2020·Granted Dec 27, 2022·11 cites·18 claims
- 0597US10837039B2Methods and means for enhancing RNA productionCUREVAC REAL ESTATE GMBH·Filed 2015·Granted Nov 17, 2020·34 cites·18 claims
- 0697US10517827B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2016·Granted Dec 31, 2019·35 cites·15 claims
- 0796US12318486B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Jun 3, 2025·3 cites·16 claims
- 0896US12138348B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Nov 12, 2024·3 cites·20 claims
- 0995US11248223B2Method of RNA in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereofCUREVAC AG·Filed 2016·Granted Feb 15, 2022·33 cites·29 claims
- 1094US11384375B2Immobilized poly(n)polymeraseCUREVAC AG·Filed 2016·Granted Jul 12, 2022·11 cites·17 claims
- 1191US11692002B2RNA sequence adaptationCureVac SE·Filed 2018·Granted Jul 4, 2023·7 cites·22 claims
- 1291US11525158B2Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNACureVac SE·Filed 2018·Granted Dec 13, 2022·8 cites·19 claims
- 1390US11608513B2Method for adding cap structures to RNA using immobilized enzymesCureVac SE·Filed 2016·Granted Mar 21, 2023·7 cites·15 claims
- 1487US2025114307A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 1585US2024218412A1Methods and means for enhancing rna productionCUREVAC MFG GMBH·Filed 2024·Application pending·0 cites
- 1685US2025195436A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 1778US12385088B2Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNACureVac SE·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 1878US2025376724A1Linear double stranded dna coupled to a single support or a tag and methods for producing said linear double stranded dnaCureVac SE·Filed 2025·Application pending·0 cites
- 1974US2022348976A1Immobilized poly(n)polymeraseCUREVAC AG·Filed 2022·Application pending·0 cites
- 2072US2024150386A1Rna sequence adaptationCureVac SE·Filed 2023·Application pending·0 cites
- 2171US2025313788A1Bioreactor for rna in vitro transcriptionCUREVAC MFG GMBH·Filed 2025·Application pending·0 cites
- 2271US2021040526A1Methods and means for enhancing rna productionCUREVAC REAL ESTATE GMBH·Filed 2020·Application pending·0 cites
- 2370US2023227881A1Method for adding cap structures to rna using immobilized enzymesCureVac SE·Filed 2023·Application pending·0 cites
- 2469US2022389470A1Method for in vitro transcription using an immobilized restriction enzymeCUREVAC AG·Filed 2022·Application pending·0 cites
- 2568US2024100142A1Method for producing rna molecule compositionsCureVac SE·Filed 2023·Application pending·0 cites
- 2667US2022119795A1Method of rna in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereofCUREVAC AG·Filed 2022·Application pending·0 cites
- 2761US12297489B2Method for determining at least one quality parameter of an RNA sampleCUREVAC MFG GMBH·Filed 2018·Granted May 13, 2025·0 cites·34 claims
- 2861US2025270634A1Method for determining at least one quality parameter of an rna sampleCUREVAC MFG GMBH·Filed 2025·Application pending·0 cites
- 2959US12371646B2Bioreactor for RNA in vitro transcriptionCUREVAC MFG GMBH·Filed 2019·Granted Jul 29, 2025·0 cites·13 claims
- 3057US2024299309A1Pharmaceutical composition comprising lipid-based carriers encapsulating rna for multidose administrationCureVac SE·Filed 2021·Application pending·0 cites
- 3153US12492425B2Methods for RNA analysisCureVac SE·Filed 2019·Granted Dec 9, 2025·0 cites·31 claims
- 3252US11684665B2Method for producing RNA molecule compositionsCureVac SE·Filed 2016·Granted Jun 27, 2023·0 cites·25 claims
- 3351US2005130260A1Refolded membrane protein in monodisperse formFiled 2003·Application pending·0 cites
- 3450US2025345524A1Syringes containing pharmaceutical compositions comprising rnaCureVac SE·Filed 2022·Application pending·0 cites
- 3549US2025263764A1Device for preparing a dna product by means of capillary polymerase chain reactionCUREVAC MFG GMBH·Filed 2021·Application pending·0 cites
- 3649US2018208957A1Method for in vitro transcription using an immobilized restriction enzymeCUREVAC AG·Filed 2016·Application pending·0 cites
- 3747US2024246056A1Manufacturing device for a pharmaceutical productCureVac RNA Printer GmbH·Filed 2021·Application pending·0 cites
- 3844US11920174B2RNA analysis by total hydrolysis and quantification of released nucleosidesCureVac SE·Filed 2017·Granted Mar 5, 2024·0 cites·20 claims
- 3944US2007031926A1Refolded membrane protein in monodisperse formLINDEN LARS·Filed 2006·Application pending·0 cites
- 4041US2021180106A1Method for analyzing rnaCUREVAC AG·Filed 2016·Application pending·0 cites
- 4141US2005255556A1Refolding of ion channel proteinsLOEBEL DIETRICH·Filed 2005·Application pending·0 cites
- 4240US2019177714A1Immobilized inorganic pyrophosphatase (ppase)CUREVAC AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →